Clinical trial · Observational
Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway (Onco-PREMs)
Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Healthcare systems are evolving, giving increasing prominence to the patient-centered model, accompanied by objective and perceived outcomes. PREMs (Patient Reported Experience Measures) are used to assess how patients feel about their experience of care. PREMs enable patients to take an active role in their own care, and enable healthcare establishments to identify areas for improvement that can be incorporated into their quality processes. In oncology, the collection of patient-perceived quality regarding their care pathway would enable better coordination of their care. While a few initiatives have emerged in the field of PREMs, the development of a reliable questionnaire assessing patient perception of their care pathway in oncology remains a challenge.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Data collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Cancer patient
- description
- Patient with cancer regardless of location or stage.
- interventionNames
- Other: Data collection
Primary outcomes (1)
- measure
- Psychometric validation
- timeFrame
- Day 0
- description
- Stastistical analysis to confirm the psychometric validation of the IGQ questionnaire
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * cancer patient * regardless of location or stage * Fluent in French * aged more than 18 years old * Agreeing to take part in the study Exclusion Criteria: * With an estimated life expectancy of less than 3 months * In remission, untreated or without follow-up for more than 12 months * Protected by law
References
Publications (0)
Data not yet available